Stock data

威健生技 (6661)

威健生技 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$35.54M, up 19.6% from a year earlier. EPS over the last four quarters totals -NT$0.06.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 威健生技 in Insightr